Emerald Advisers’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,876
| Closed | -$1.03M | – | 312 |
|
|
2021
Q1 | $1.03M | Sell |
12,876
-279,678
| -96% | -$21.8M | 0.04% | 148 |
|
|
2020
Q4 | $23.1M | Buy |
292,554
+282,740
| +2,881% | +$16.6M | 0.77% | 53 |
|
|
2020
Q3 | $431K | Buy |
9,814
+1,391
| +17% | +$68.5K | 0.02% | 192 |
|
|
2020
Q2 | $373K | Buy |
8,423
+2,315
| +38% | +$86.4K | 0.02% | 197 |
|
|
2020
Q1 | $219K | Buy |
+6,108
| New | +$347K | 0.01% | 198 |
|
|
2017
Q1 | – | Sell |
-149,939
| Closed | -$11.8M | – | 276 |
|
|
2016
Q4 | $11.8M | Buy |
149,939
+35,495
| +31% | +$2.76M | 0.5% | 81 |
|
|
2016
Q3 | $8.92M | Sell |
114,444
-17,530
| -13% | -$1.27M | 0.4% | 91 |
|
|
2016
Q2 | $9.07M | Sell |
131,974
-62,330
| -32% | -$4.3M | 0.44% | 82 |
|
|
2016
Q1 | $13.9M | Sell |
194,304
-58,392
| -23% | -$3.67M | 0.68% | 53 |
|
|
2015
Q4 | $15.7M | Buy |
252,696
+43,545
| +21% | +$2.66M | 0.74% | 41 |
|
|
2015
Q3 | $11.9M | Buy |
209,151
+40,905
| +24% | +$2.17M | 0.62% | 53 |
|
|
2015
Q2 | $9.03M | Buy |
168,246
+115,056
| +216% | +$5.6M | 0.43% | 79 |
|
|
2015
Q1 | $2.53M | Buy |
+53,190
| New | +$2.35M | 0.13% | 190 |
|
Emerald Advisers's CMD Position: Q2 2021 in Review
Emerald Advisers sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 12,876 shares — an estimated $1.03M sold.
Emerald Advisers first reported a position in CMD in Q1 2015 and held it in 13 quarters. The position peaked at $23.1M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Emerald Advisers reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Emerald Advisers sold 12,876 Cantel Medical Corporation shares in Q2 2021, an estimated $1.03M.
- Emerald Advisers first reported a position in Cantel Medical Corporation in Q1 2015 and held it in 13 quarters.
- Emerald Advisers's Cantel Medical Corporation position peaked at $23.1M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Emerald Advisers's 13F filing for Q2 2021, filed 29 Jul 2021.